[
  {
    "ts": null,
    "headline": "Is it Prudent to Retain Charles River Stock in Your Portfolio Now?",
    "summary": "CRL sees momentum in drug discovery and safety services, but macro pressures and currency headwinds threaten growth.",
    "url": "https://finnhub.io/api/news?id=7c53d43414a64052082c19c7a3b064035ee7794d7d88eeae868ae16d1b5d633a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752668340,
      "headline": "Is it Prudent to Retain Charles River Stock in Your Portfolio Now?",
      "id": 135966617,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "CRL sees momentum in drug discovery and safety services, but macro pressures and currency headwinds threaten growth.",
      "url": "https://finnhub.io/api/news?id=7c53d43414a64052082c19c7a3b064035ee7794d7d88eeae868ae16d1b5d633a"
    }
  }
]